New drug combo shows promise against prostate cancer in trials
A multinational, phase 3 clinical trial – TALAPRO-2 – tested whether the combination of two medicines, talazoparib and enzalutamide, may
Read more
A multinational, phase 3 clinical trial – TALAPRO-2 – tested whether the combination of two medicines, talazoparib and enzalutamide, may
Read moreWe use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This
Read moreDr Julia Jones discusses lifestyle changes to help prevent dementia We use your sign-up to provide content in ways you’ve
Read moreWorld TB Day on March 24th will commemorate the day in 1882 when Professor Robert Koch announced in Berlin that
Read moreWe use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This
Read moreSource: Read Full Article
Read moreChildren living in neighborhoods with low opportunities for health have an increased risk for child and caregiver mortality, according to
Read moreAlthough rates of colorectal cancer (CRC) are on the decline, the incidence among younger people continues to rise. Data show
Read moreFor patients with severe community-acquired pneumonia admitted to the intensive care unit (ICU), hydrocortisone is associated with a lower risk
Read more